A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects
Clinical trial NCT05653037 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05653037
- Sponsor
- Suzhou Ribo Life Science Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2025-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.